Products

Amoxicillin for Oral Suspension with GMP 125mg /5ml, 250mg/5ml

China Amoxicillin for Oral Suspension with GMP 125mg/5ml, 250mg/5ml, Find details about China 125mg, Drug from Amoxicillin for Oral Suspension with GMP 125mg/5ml, 250mg/5ml

Model NO.
125mg/5ml, 250mg/5ml
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
H37021926
Drug Ad Approval No.
2020r002185
Packing-1
10capsule/Blister, 10blister/Box, 100 Boxes/Carton
Packing-2
1000capsule/Plastic Tin, 40 Tins/Carton
Packing-3
500capsule/Plastic Tin, 40 Tins/Carton
Capsule Body
0#, 1#, 2# and So on
Trademark
Reyoung
Transport Package
10capsules/Blister,10blisters/Box,100boxes/Carton
Specification
250mg 500mg 125mg
Origin
China
HS Code
3004101200
Model NO.
125mg/5ml, 250mg/5ml
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
H37021926
Drug Ad Approval No.
2020r002185
Packing-1
10capsule/Blister, 10blister/Box, 100 Boxes/Carton
Packing-2
1000capsule/Plastic Tin, 40 Tins/Carton
Packing-3
500capsule/Plastic Tin, 40 Tins/Carton
Capsule Body
0#, 1#, 2# and So on
Trademark
Reyoung
Transport Package
10capsules/Blister,10blisters/Box,100boxes/Carton
Specification
250mg 500mg 125mg
Origin
China
HS Code
3004101200
Product nameAmoxicillin for oral suspension
Specification125mg/5ml,250mg/5ml
CertificationGMP ISO9001 ISO14001
StandardBP
Reyoung Pharmaceutical Co., Ltd., established in 1966, is one of the leading manufacturer and distributor of pharmaceutical products in China. Reyoung Pharma is an GMP, ISO9001, ISO14001, OHS18001 authentication enterprise and so on. The trademark "REYOUNG" is famous trademark of China.
Reyoung Pharma has three main factories which covers an area of 1,000,000 square meters and owns total asset of more than 1.5 billion USD dollar. There is more than 5000 staff in Reyoung Pharma, of whom approximate 21 percent of the total staff is sales & marketing personnel. Reyoung Pharma has 30 workshops that can produce ten categories and more than 400 specifications of pharmaceutical products including tablets, capsules, granules, sterile active ingredients, small volume injection, powder for injection, lyophilized powder for injection, suppository, traditional Chinese medicine and aerosol. The annual production capacity can reach 2.5 billion vials of powder for injection, 300 million ampoules of liquid injection, 4 billion tablets, 6 billion capsules and 200 million bags granule of solid formulation, and 2000 tons API respectively. As a professional pharmaceutical manufacturer, Reyoung Pharma is the first enterprise to manufacture powder for injection in Shandong province. The sales and marketing network for its products covers all the big and medium cities through the mainland of PRC and also has been successfully covered more than 70 countries all over the world. In order to praise Reyoung Pharma making so much contribution to Chinese pharmaceutical industry, the government granted many awards and certifications, such as state-focused high & new tech enterprise of China, national contract-stressing and promise-keeping enterprise of China, the production base of cephalosporin raw material, advanced Collective of pharmaceutical industry of Shandong province and so on.
Reyoung Pharma commenced international business and exported products in 1997. Reyoung Pharma, with an excellent sales&documentation team, owned over 20 years experience in the international transaction and registered products in different countries. Reyoung Pharma has passed the GMP inspection of Colombia, Peru, Congo, Ethiopia, Uganda, Nigeria, Ghana, Tanzania, Kenya, Cote d′Ivoire, Pakistan, Ukraine, Philippines, Cambodia, etc. Products have been exported to Asia, South America, Africa, CIS Countries, Middle East and Europe including Thailand, Philippines, Cambodia, Hong Kong, Vietnam, India, Pakistan, Colombia, Peru, Chile, Costa Rica, Venezuela, Congo, Ethiopia, Uganda, Nigeria, Tanzania, Kenya, Cameroon, Russia, Kazakhstan, Ukraine, Uzbekistan, Georgia, Yemen, Iraq, Germany, Denmark, and so on.
Look into the future, as entering into the market successively of the new products, the product structure of Reyoung Pharma will be upgraded, the producing levels and the market-controlling power will be enhanced further, and Reyoung Pharma will provide a wider platform for our old and new friends to go hand in hand and seek common development.
 

You Might Also Like